Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
56,940published records in database
4recall categories represented
Jun 28, 2023newest stored source record
Latest records
Latest recalls — page 548
The newest recall records with useful source details are listed here.
Medtronic has identified that the logfiles downloaded from the recently updated Model 1521 monitors (Serial Numbers: MON4xxxxxx for OUS and MON5xxxxxx for US), are unable to be processed by…
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There are potential risks of the Hemospray powder adhering to the distal end of the endoscope, which can result in adhesion of the endoscope to tissue and consequent difficulty or inability…
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Packaging for a serrated blade applicator kit (12 Sample) may contain a serrated blade applicator (18 sample). This results in a characteristic pattern of missed or light samples on the…
The sensors may experience an out-of-box failure because after recalibration, the sensors stayed in the software mode "production" and were not reset to "released" mode.
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)